Colorectal cancer is a deadly disease but can be treatable if caught early, making colorectal cancer screenings vital. A recent study published in JAMA Oncology suggests that the interval between colonoscopies could potentially be extended from 10 to 15 years for individuals with a negative initial screening and no family history of colorectal cancer. Researchers found that extending the time period between colonoscopies for this group would only miss two colorectal cancer cases per 1,000 individuals. The study out of Sweden analyzed data from over 100,000 individuals and found that the risks of colorectal cancer and colorectal cancer-specific death were lower for 15 years in the exposed group, suggesting that extending the screening interval could be beneficial in avoiding unnecessary invasive procedures.
Dr. Anton Bilchik, a surgical oncologist and chief of medicine at Providence Saint John’s Cancer Institute in California, cautions that the study is a cohort study and therefore the results should be interpreted cautiously. He notes that the study does not provide data on how colonoscopies done every 15 years may reduce complications or how the benefits of reducing colonoscopies outweigh the risks. Bilchik also highlights the importance of stool-based tests as an alternative screening method for individuals who may not need frequent colonoscopies. He emphasizes that early detection and screening are crucial in the fight against colorectal cancer, especially as there has been an alarming increase in cases among younger people.
Dr. Dale Whitebloom, the chief medical officer at U.S. Digestive Health, echoes the importance of early detection and screening for colorectal cancer. He stresses that awareness is key, especially among younger individuals, who may not be aware of the risk factors and symptoms of colorectal cancer. Whitebloom emphasizes the need for individuals to have access to the most up-to-date recommendations and effective screening tools in order to detect colorectal cancer at an early stage when treatments are most successful.
Overall, the study’s findings suggest that extending the interval between colonoscopies for individuals with a negative initial screening and no family history of colorectal cancer may be a viable option. However, further research is needed to fully understand the implications of extending the screening interval and how it may impact the detection and prevention of colorectal cancer. It is important for individuals to stay informed about the latest recommendations for colorectal cancer screening and to work with healthcare providers to determine the best screening schedule based on individual risk factors and needs. Increasing awareness and access to screening tools can help combat this deadly disease and improve outcomes for those at risk of colorectal cancer.
